Literature DB >> 19246515

Conformational effects of Lys191 in the human GnRH receptor: mutagenesis and molecular dynamics simulations studies.

Eduardo Jardón-Valadez1, Arturo Aguilar-Rojas, Guadalupe Maya-Núñez, Alfredo Leaños-Miranda, Angel Piñeiro, P Michael Conn, Alfredo Ulloa-Aguirre.   

Abstract

In the present study, we analyzed the role of Lys191 on function, structure, and dynamic behavior of the human GnRH receptor (hGnRHR) and the formation of the Cys14-Cys200 bridge, which is essential for receptor trafficking to the plasma membrane. Several mutants were studied; mutants lacked either the Cys14-Cys200 bridge, Lys191 or both. The markedly reduced expression and function of a Cys14Ser mutant lacking the 14-200 bridge, was nearly restored to wild-type/DeltaLys191 levels upon deletion of Lys191. Lys191 removal resulted in changes in the dynamic behavior of the mutants as disclosed by molecular dynamics simulations: the distance between the sulfur- (or oxygen-) sulfur groups of Cys (or Ser)14 and Cys200 was shorter and more constant, and the conformation of the NH(2)-terminus and the exoloop 2 exhibited fewer fluctuations than when Lys191 was present. These data provide novel information on the role of Lys191 in defining an optimal configuration for the hGnRHR intracellular trafficking and function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246515      PMCID: PMC2829749          DOI: 10.1677/JOE-08-0527

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  34 in total

1.  Disulfide bonds and protein folding

Authors: 
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

2.  A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6.

Authors:  Chris Oostenbrink; Alessandra Villa; Alan E Mark; Wilfred F van Gunsteren
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 3.  Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.

Authors:  Alfredo Ulloa-Aguirre; Jo Ann Janovick; Shaun P Brothers; P Michael Conn
Journal:  Traffic       Date:  2004-11       Impact factor: 6.215

4.  Specializations of a G-protein-coupled receptor that appear to aid with detection of frequency-modulated signals from its ligand.

Authors:  Jo Ann Janovick; Shaun P Brothers; Paul E Knollman; P Michael Conn
Journal:  FASEB J       Date:  2006-12-15       Impact factor: 5.191

5.  Gonadotropin-releasing hormone receptors with intracellular carboxyl-terminal tails undergo acute desensitization of total inositol phosphate production and exhibit accelerated internalization kinetics.

Authors:  A Heding; M Vrecl; J Bogerd; A McGregor; R Sellar; P L Taylor; K A Eidne
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

6.  Static and dynamic roles of extracellular loops in G-protein-coupled receptors: a mechanism for sequential binding of thyrotropin-releasing hormone to its receptor.

Authors:  A O Colson; J H Perlman; A Smolyar; M C Gershengorn; R Osman
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

Review 7.  The tail of the gonadotrophin-releasing hormone receptor: desensitization at, and distal to, G protein-coupled receptors.

Authors:  C A McArdle; J S Davidson; G B Willars
Journal:  Mol Cell Endocrinol       Date:  1999-05-25       Impact factor: 4.102

8.  Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target.

Authors:  Jo Ann Janovick; Guadalupe Maya-Nunez; P Michael Conn
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

9.  Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms.

Authors:  R J Santen; C W Bardin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

10.  Effects of Asn318 and Asp87Asn318 mutations on signal transduction by the gonadotropin-releasing hormone receptor and receptor regulation.

Authors:  W M Awara; C H Guo; P M Conn
Journal:  Endocrinology       Date:  1996-02       Impact factor: 4.736

View more
  10 in total

Review 1.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

2.  Biochemical mechanism of pathogenesis of human gonadotropin-releasing hormone receptor mutants Thr104Ile and Tyr108Cys associated with familial hypogonadotropic hypogonadism.

Authors:  Guadalupe Maya-Núñez; Jo Ann Janovick; Arturo Aguilar-Rojas; Eduardo Jardón-Valadez; Alfredo Leaños-Miranda; Teresa Zariñan; Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2011-01-26       Impact factor: 4.102

Review 3.  Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; James A Dias; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

Review 4.  Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Adv Pharmacol       Date:  2011

Review 5.  Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Trends Endocrinol Metab       Date:  2009-12-11       Impact factor: 12.015

Review 6.  Transitioning pharmacoperones to therapeutic use: in vivo proof-of-principle and design of high throughput screens.

Authors:  P Michael Conn; David C Smithson; Peter S Hodder; M David Stewart; Richard R Behringer; Emery Smith; Alfredo Ulloa-Aguirre; Jo Ann Janovick
Journal:  Pharmacol Res       Date:  2013-12-25       Impact factor: 7.658

7.  Molecular dynamics simulation of the follicle-stimulating hormone receptor. Understanding the conformational dynamics of receptor variants at positions N680 and D408 from in silico analysis.

Authors:  Eduardo Jardón-Valadez; Derik Castillo-Guajardo; Iván Martínez-Luis; Rubén Gutiérrez-Sagal; Teresa Zariñán; Alfredo Ulloa-Aguirre
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

Review 8.  Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs.

Authors:  Maira Huerta-Reyes; Guadalupe Maya-Núñez; Marco Allán Pérez-Solis; Eunice López-Muñoz; Nancy Guillén; Jean-Christophe Olivo-Marin; Arturo Aguilar-Rojas
Journal:  Front Oncol       Date:  2019-10-01       Impact factor: 6.244

Review 9.  Misfolded G Protein-Coupled Receptors and Endocrine Disease. Molecular Mechanisms and Therapeutic Prospects.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; Eduardo Jardón-Valadez
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

10.  Novel Crizotinib-GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems.

Authors:  József Murányi; Attila Varga; Pál Gyulavári; Kinga Pénzes; Csilla E Németh; Miklós Csala; Lilla Pethő; Antal Csámpai; Gábor Halmos; István Peták; István Vályi-Nagy
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.